These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 16939967

  • 1. Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: role of Lamivudine prophylaxis.
    Coiffier B.
    Cancer Invest; 2006; 24(5):548-52. PubMed ID: 16939967
    [Abstract] [Full Text] [Related]

  • 2. A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?
    Long M, Jia W, Li S, Jin L, Wu J, Rao N, Feng H, Chen K, Deng H, Liu F, Su F, Song E.
    Breast Cancer Res Treat; 2011 Jun; 127(3):705-12. PubMed ID: 21445574
    [Abstract] [Full Text] [Related]

  • 3. Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy--a prospective case series.
    Vassiliadis T, Garipidou V, Tziomalos K, Perifanis V, Giouleme O, Vakalopoulou S.
    Am J Hematol; 2005 Nov; 80(3):197-203. PubMed ID: 16247746
    [Abstract] [Full Text] [Related]

  • 4. The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma.
    He YF, Li YH, Wang FH, Jiang WQ, Xu RH, Sun XF, Xia ZJ, Huang HQ, Lin TY, Zhang L, Bao SP, He YJ, Guan ZZ.
    Ann Hematol; 2008 Jun; 87(6):481-5. PubMed ID: 18299831
    [Abstract] [Full Text] [Related]

  • 5. Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy.
    Leaw SJ, Yen CJ, Huang WT, Chen TY, Su WC, Tsao CJ.
    Ann Hematol; 2004 May; 83(5):270-5. PubMed ID: 15060745
    [Abstract] [Full Text] [Related]

  • 6. Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.
    Dai MS, Chao TY, Kao WY, Shyu RY, Liu TM.
    Ann Hematol; 2004 Dec; 83(12):769-74. PubMed ID: 15338194
    [Abstract] [Full Text] [Related]

  • 7. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
    Huang H, Cai Q, Lin T, Lin X, Liu Y, Gao Y, Peng R.
    Expert Opin Pharmacother; 2009 Oct; 10(15):2399-406. PubMed ID: 19761353
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy.
    Koo YX, Tan DS, Tan IB, Tao M, Chow WC, Lim ST.
    Cancer; 2010 Jan 01; 116(1):115-21. PubMed ID: 19899164
    [Abstract] [Full Text] [Related]

  • 9. Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients.
    Yeo W, Ho WM, Hui P, Chan PK, Lam KC, Lee JJ, Johnson PJ.
    Breast Cancer Res Treat; 2004 Dec 01; 88(3):209-15. PubMed ID: 15609123
    [Abstract] [Full Text] [Related]

  • 10. A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Endo T, Sakai T, Fujimoto K, Yamamoto S, Takashima H, Haseyama Y, Nishio M, Koizumi K, Koike T, Sawada K.
    Bone Marrow Transplant; 2001 Feb 01; 27(4):433-6. PubMed ID: 11313673
    [Abstract] [Full Text] [Related]

  • 11. [Nucleos(t)ides as prophylaxis for the reactivation of hepatitis B virus in immunosuppressed patients].
    Fan LY, Zhou Z, Zhong S, Ling N, Wang ZY, Shi XF, Zhang DZ, Ren H.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun 01; 17(6):429-33. PubMed ID: 19567021
    [Abstract] [Full Text] [Related]

  • 12. Lamivudine for chemotherapy-induced reactivation of HBV: prophylaxis or treatment?
    Mancuso A, Pagliaro L.
    Am J Gastroenterol; 2002 May 01; 97(5):1268-9. PubMed ID: 12014746
    [No Abstract] [Full Text] [Related]

  • 13. Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma.
    Li YH, He YF, Jiang WQ, Wang FH, Lin XB, Zhang L, Xia ZJ, Sun XF, Huang HQ, Lin TY, He YJ, Guan ZZ.
    Cancer; 2006 Mar 15; 106(6):1320-5. PubMed ID: 16470607
    [Abstract] [Full Text] [Related]

  • 14. Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma.
    Tsutsumi Y, Tanaka J, Kawamura T, Miura T, Kanamori H, Obara S, Asaka M, Imamura M, Masauzi N.
    Ann Hematol; 2004 Jan 15; 83(1):58-60. PubMed ID: 14513286
    [Abstract] [Full Text] [Related]

  • 15. Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection.
    Ahmed A, Keeffe EB.
    Am J Gastroenterol; 1999 Jan 15; 94(1):249-51. PubMed ID: 9934765
    [Abstract] [Full Text] [Related]

  • 16. [Hepatitis B virus reactivation after cessation of prophylactic lamivudine therapy in B-cell lymphoma patients treated with rituximab combined CHOP therapy].
    Mimura N, Tsujimura H, Ise M, Sakai C, Kojima H, Fukai K, Yokosuka O, Takagi T, Kumagai K.
    Rinsho Ketsueki; 2009 Dec 15; 50(12):1715-9. PubMed ID: 20068280
    [Abstract] [Full Text] [Related]

  • 17. Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B.
    Huang YH, Hsiao LT, Hong YC, Chiou TJ, Yu YB, Gau JP, Liu CY, Yang MH, Tzeng CH, Lee PC, Lin HC, Lee SD.
    J Clin Oncol; 2013 Aug 01; 31(22):2765-72. PubMed ID: 23775967
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.
    Picardi M, Pane F, Quintarelli C, De Renzo A, Del Giudice A, De Divitiis B, Persico M, Ciancia R, Salvatore F, Rotoli B.
    Haematologica; 2003 Nov 01; 88(11):1296-303. PubMed ID: 14607759
    [Abstract] [Full Text] [Related]

  • 19. [Effect of lamivudine for hepatitis B virus reactivation in blood cancer patients undergoing immunosuppressive chemotherapy].
    Sugimoto R, Enjoji M, Kotoh K, Noguchi K, Tsuruta S, Nakamuta M, Nawata H.
    Fukuoka Igaku Zasshi; 2004 Oct 01; 95(10):274-9. PubMed ID: 15678886
    [Abstract] [Full Text] [Related]

  • 20. Lamivudine prophylaxis in HBV carriers with haemato-oncological malignancies who receive chemotherapy.
    Idilman R.
    J Antimicrob Chemother; 2005 Jun 01; 55(6):828-31. PubMed ID: 15849263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.